Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Publish with us

Conference speaker

Mark Waller


Mark Waller

Pending AI

Within both academic and commercial environments, Prof. Mark Waller has over fifteen years of experience in solving large-scale, complex challenges in biology and chemistry using artificial intelligence and quantum mechanics. He is the Founder and Chief Executive Officer of Pending AI – a venture-backed scale-up company commercialising sophisticated solutions to enrich the small molecule development value chain.

In fruitful partnership with Elsevier, Pending AI is utilising artificial intelligence to revolutionise small molecule synthesis planning, allowing for the streamlining of an otherwise operational- and cost-intensive process. This next-generation retrosynthesis solution, available through the Reaxys platform, has attracted a lot of interest from pharmaceutical and agrochemical companies, chemical manufacturers, as well as academic and government institutions globally.